Matches in SemOpenAlex for { <https://semopenalex.org/work/W2313692715> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2313692715 abstract "The purpose of this study is to characterize protein markers in African American breast tumors that correspond to different tumor subtypes, recurrence, and survival. Tissue microarrays (TMA) have been used because they have the advantage of analyzing numerous samples on a single slide and can be used in clinical pathology laboratories. Protein markers that have been used are estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (Her2), cyclin A2, cytokeratin 5, vimentin, Bcl2, and Ki67. TMA have been prepared and stained for proteins that will distinguish 5 tumor subtypes: luminal A (ER+ and/or PR+ Her2-); luminal B (ER+ and/or PR+ Her2- Cyclin A2+ and/or Ki67+); luminal B Her2+ (ER+ and/or PR+ Her2+); Her2+ (ER- PR- Her2+), and triple negative (ER- PR- Her2-). These subtypes are known to be associated with different relapse-free survival and overall survival. Luminal B tumors have the same ER+PR+HER2- profile as luminal A tumors; however, luminal B tumors have a poor prognosis, whereas luminal A tumors have the best prognosis of all 5 subtypes. Luminal B tumors can be distinguished from luminal A tumors by staining for cell cycle proteins Cyclin A2 or Ki67, which promote cell proliferation. Cyclin A2 was more frequently expressed than Ki67 in tumors with poor prognosis such as luminal B (ER+PR+HER-) and ER-PR-HER2- (triple negative) tumors. Therefore, Cyclin A2+ may better serve to identify luminal B and triple negative tumors with a poor prognosis and thus aid physicians in treatment decisions. The RASSF1A protein has been reported to inhibit the transcription of Cyclin A2. Methylation of the RASSF1A promoter is expected to decrease RASSF1A transcription and thereby increase Cyclin A2 transcription and protein levels. Significantly increased levels of RASSF1A methylation have been observed in this laboratory with AA ER-PR-HER- breast cancer patients compared to mammoplasty samples. Thus, increased Cyclin A2 protein staining correlated with increased RASSF1A methylation. This is one molecular explanation for elevated cyclin A2 protein levels in triple negative tumors. Discovery of molecular markers and subtypes that are most prevalent in African Americans could lead to a better treatment, targets for therapy, and understanding of the factors contributing to higher mortality in this group compared to other groups. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1699. doi:1538-7445.AM2012-1699" @default.
- W2313692715 created "2016-06-24" @default.
- W2313692715 creator A5012743213 @default.
- W2313692715 creator A5025576841 @default.
- W2313692715 creator A5036100864 @default.
- W2313692715 creator A5072009419 @default.
- W2313692715 creator A5083800928 @default.
- W2313692715 creator A5089513015 @default.
- W2313692715 date "2012-04-15" @default.
- W2313692715 modified "2023-09-24" @default.
- W2313692715 title "Abstract 1699: Breast cancer protein markers in African Americans" @default.
- W2313692715 doi "https://doi.org/10.1158/1538-7445.am2012-1699" @default.
- W2313692715 hasPublicationYear "2012" @default.
- W2313692715 type Work @default.
- W2313692715 sameAs 2313692715 @default.
- W2313692715 citedByCount "0" @default.
- W2313692715 crossrefType "proceedings-article" @default.
- W2313692715 hasAuthorship W2313692715A5012743213 @default.
- W2313692715 hasAuthorship W2313692715A5025576841 @default.
- W2313692715 hasAuthorship W2313692715A5036100864 @default.
- W2313692715 hasAuthorship W2313692715A5072009419 @default.
- W2313692715 hasAuthorship W2313692715A5083800928 @default.
- W2313692715 hasAuthorship W2313692715A5089513015 @default.
- W2313692715 hasConcept C121608353 @default.
- W2313692715 hasConcept C126322002 @default.
- W2313692715 hasConcept C142724271 @default.
- W2313692715 hasConcept C147447768 @default.
- W2313692715 hasConcept C16438837 @default.
- W2313692715 hasConcept C193270364 @default.
- W2313692715 hasConcept C199835354 @default.
- W2313692715 hasConcept C204232928 @default.
- W2313692715 hasConcept C2779012181 @default.
- W2313692715 hasConcept C2780110267 @default.
- W2313692715 hasConcept C29537977 @default.
- W2313692715 hasConcept C502942594 @default.
- W2313692715 hasConcept C530470458 @default.
- W2313692715 hasConcept C71924100 @default.
- W2313692715 hasConcept C84606932 @default.
- W2313692715 hasConcept C86803240 @default.
- W2313692715 hasConcept C98717036 @default.
- W2313692715 hasConceptScore W2313692715C121608353 @default.
- W2313692715 hasConceptScore W2313692715C126322002 @default.
- W2313692715 hasConceptScore W2313692715C142724271 @default.
- W2313692715 hasConceptScore W2313692715C147447768 @default.
- W2313692715 hasConceptScore W2313692715C16438837 @default.
- W2313692715 hasConceptScore W2313692715C193270364 @default.
- W2313692715 hasConceptScore W2313692715C199835354 @default.
- W2313692715 hasConceptScore W2313692715C204232928 @default.
- W2313692715 hasConceptScore W2313692715C2779012181 @default.
- W2313692715 hasConceptScore W2313692715C2780110267 @default.
- W2313692715 hasConceptScore W2313692715C29537977 @default.
- W2313692715 hasConceptScore W2313692715C502942594 @default.
- W2313692715 hasConceptScore W2313692715C530470458 @default.
- W2313692715 hasConceptScore W2313692715C71924100 @default.
- W2313692715 hasConceptScore W2313692715C84606932 @default.
- W2313692715 hasConceptScore W2313692715C86803240 @default.
- W2313692715 hasConceptScore W2313692715C98717036 @default.
- W2313692715 hasLocation W23136927151 @default.
- W2313692715 hasOpenAccess W2313692715 @default.
- W2313692715 hasPrimaryLocation W23136927151 @default.
- W2313692715 hasRelatedWork W1734587641 @default.
- W2313692715 hasRelatedWork W2023940796 @default.
- W2313692715 hasRelatedWork W2057491561 @default.
- W2313692715 hasRelatedWork W2085392306 @default.
- W2313692715 hasRelatedWork W2226961406 @default.
- W2313692715 hasRelatedWork W2312907762 @default.
- W2313692715 hasRelatedWork W2314576053 @default.
- W2313692715 hasRelatedWork W2327837002 @default.
- W2313692715 hasRelatedWork W2328495265 @default.
- W2313692715 hasRelatedWork W2350701717 @default.
- W2313692715 hasRelatedWork W2399833957 @default.
- W2313692715 hasRelatedWork W2416710141 @default.
- W2313692715 hasRelatedWork W2479867457 @default.
- W2313692715 hasRelatedWork W2519950499 @default.
- W2313692715 hasRelatedWork W2591177584 @default.
- W2313692715 hasRelatedWork W2725923139 @default.
- W2313692715 hasRelatedWork W2896126206 @default.
- W2313692715 hasRelatedWork W2978801233 @default.
- W2313692715 hasRelatedWork W3036079300 @default.
- W2313692715 hasRelatedWork W3198501627 @default.
- W2313692715 isParatext "false" @default.
- W2313692715 isRetracted "false" @default.
- W2313692715 magId "2313692715" @default.
- W2313692715 workType "article" @default.